Ideas to action: independent research for global prosperity
Malaria
More from the Series
Blog Post
September 17, 2012
UNITAID: maybe you’ve heard of it, or maybe not. Launched in 2006, UNITAID has lived in the shadow of its older and bigger global-health siblings (the Global Fund, GAVI, and PEPFAR, to name a few). Perhaps due to its relative obscurity and late entry to a crowded global-health field, UNITAID has pro...
Blog Post
September 05, 2012
In this austere budget climate, generating “value for money” (VFM) is a top concern for global health funding agencies and their donors, who want the biggest bang for their buck in terms of lives saved and diseases controlled. To this end, CGD has convened a working group to help shape the VFM agend...
Blog Post
September 04, 2012
This is a joint post with Heather Lanthorn, a doctoral candidate at Harvard School of Public Health.
In mid-July, amidst the busy global-health month of July, in between the Family Planning summit and the AIDS conference, the near-final draft of the independent evaluation of the Affordable Me...
Blog Post
February 09, 2012
Published last week in The Lancet, a new study by the Institute for Health Metrics and Evaluation (IHME) finds that there were 1.2 million deaths from malaria in 2010, not 655 thousand as estimated by the WHO. Following its release, headlines began splashing uncritically: “Malaria kills twice as man...
Blog Post
October 24, 2011
News this month that an experimental vaccine cuts in half the risk of malaria in children in Africa is a welcome success story 20+ years in the making. It’s also a rare bright spot in the clinical trials labyrinth that stands between promising new medicines, vaccines, and diagnostic techniques and t...